Eliminating Trachoma in Areas with Limited Disease

Autor: Bruce D. Gaynor, Yinghui Miao, Vicky Cevallos, Hem Jha, JSP Chaudary, Ramesh Bhatta, Susan Osaki-Holm, Elizabeth Yi, Julius Schachter, John P. Whitcher, Thomas Lietman

Publikováno v: Emerging Infectious Diseases, Vol 9, Iss 5, Pp 596-598 (2003)

The common wisdom is that a trachoma program cannot eliminate ocular chlamydia from a community, just reduce infection to a level where there would be minimal blindness. We describe the success of multiple mass antibiotic treatments, demonstrating th

Externí odkaz: https://doaj.org/article/b2c61a5d94194551b6da096dc35803cc

Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal

Autor: Holm Susan Osaki, Jha Hem C., Bhatta Ramesh C., Chaudhary J.S.P., Thapa B.B., Davis Dale, Pokhrel Ram Prasad, Yinghui Miao, Zegans Michael, Schachter Julius, Frick Kevin D., Tapert Lisa, Lietman Thomas M.

Publikováno v: Bulletin of the World Health Organization, Vol 79, Iss 3, Pp 194-200 (2001)

OBJECTIVE: The study compares the effectiveness of two strategies for distributing azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The two strategies investigated were the use of azithromycin for 1) mass treatment of

Externí odkaz: https://doaj.org/article/d678cb263a5d4201a7aa48587d8d05c5

Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?

Autor: Yinghui Miao, Puning Zhao, Anne Paxton, Jocelyn Thein, Jingjing Xu, Julius Schachter, Michèle Mabon, Hansheng Liu, Susan Osaki-Holm, Louis D. Pizzarello, Lisa Tapert, H C Jha, Thomas M. Lietman

Publikováno v: Ophthalmic Epidemiology. 9:263-269

The WHO has initiated a global program to eliminate trachoma. This program includes mass antibiotic administrations to reduce the prevalence of Chlamydia trachomatis, the causative agent in trachoma. DNA amplification tests are the most sensitive met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a50c13f11740de242165d714fba036
https://doi.org/10.1076/opep.9.4.263.1508

Eliminating trachoma in areas with limited disease

Autor: Julius Schachter, Elizabeth Yi, Susan Osaki-Holm, Thomas M. Lietman, H C Jha, Vicky Cevallos, Yinghui Miao, John P. Whitcher, J.S.P. Chaudary, Bruce D. Gaynor, Ramesh C. Bhatta

Publikováno v: Emerging infectious diseases, vol 9, iss 5
Emerging Infectious Diseases, Vol 9, Iss 5, Pp 596-598 (2003)
Emerging Infectious Diseases
Gaynor, BD; Miao, Y; Cevallos, V; Jha, H; Chaudary, JSP; Bhatta, R; et al.(2003). Eliminating trachoma in areas with limited disease. Emerging Infectious Diseases, 9(5), 596-598. doi: 10.3201/eid0905.020577. UCSF: Retrieved from: http://www.escholarship.org/uc/item/49c997br

The common wisdom is that a trachoma program cannot eliminate ocular chlamydia from a community, just reduce infection to a level where there would be minimal blindness. We describe the success of multiple mass antibiotic treatments, demonstrating th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba35d27558110c23e5e1bd7fa0c6fada
https://escholarship.org/uc/item/49c997br

Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year

Autor: H C Jha, Susan Osaki Holm, K A Holbrook, J.S.P. Chaudhary, Bruce D. Gaynor, Ramesh C. Bhatta, Thomas M. Lietman, John P. Whitcher

Publikováno v: British Journal of Ophthalmology. 87:147-148

Aims: To determine if macrolide resistant Streptococcus pneumoniae will be a major concern in areas that receive annual mass azithromycin distributions for trachoma. Methods: A cross sectional survey was conducted of nasopharyngeal S pneumoniae isola

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac560202feda82b8138a2278f3c8364e
https://doi.org/10.1136/bjo.87.2.147